Skip to main content
. 2016 Jan 19;11(3):1917–1922. doi: 10.3892/ol.2016.4127

Table II.

Clinical outcome in adult patients with B-cell acute lymphoblastic leukemia, according to LMO2 expression.

Clinical outcome Total, n (%) High LMO2 expression, n (%) Low LMO2 expression, n (%) P-value
Total 85 (100.0)   46 (46.0) 39 (39.0)
Complete remission 62 (72.9)   38 (82.6) 24 (61.5) 0.03
Refractory disease 12 (14.1)   6 (13.0)   6 (15.3) 0.87
Mortality induction 11 (12.9) 2 (4.3)   9 (23.0) 0.03
Relapse risk 25 (29.4)   8 (17.3) 17 (43.5) 0.01

LMO2, LIM domain only protein 2.